Sydney is expecting a flu epidemic this winter.
The 'flu' is a respiratory disease caused by a contagious virus.
The 'flu' can cause some people to become quite unwell.
HHMP is trialling a new drug called 'Peramavir' for the treatment of the flu.
The purpose of this trial is to prove the safety and efficacy of this new treatment.
To be eligible for this trial, you must have flu symptoms for less than 48hours such as:
- cough
- sore throat
- runny nose
- headache
- chills/fever
- aches and fatigue
Study participants will be reimbursed to travel to HHMP for study visits.
(Make sure you see a doctor in the practice within 48hrs of the onset of your flu symptoms)
Information on the study provided herein is extracted from the consent form approved by the relevant Ethics Board– potential participants in the study should obtain the approved consent form for their review.
PLEASE SEE ALSO CLINICAL TRIALS OVERVIEW
For more information, or a copy of the Consent Form, please email us at trials@holdsworthhouse.com.au
Or call the trials team on (02) 9331 7228
CLINICAL TRIALS INFORMATION
Clinical Trials Home | Current Clinical Trials | About The Research Unit | Clinical Trials Overview
Benefits |
Questions & Answers | Further Information/Contact
|
